BIO — Bio-Rad Laboratories Inc. price, chart and key statistics

Price data

Price

$377.71

Change YTD

+24.66%

Next earnings

Nov 4, 2026

Market cap

10.1B2016-12 5.4B2026-09 10.1B+86.7% over the window

Enterprise value

9.5B

Shares outstanding

26.7M2016-06 29.6M2026-06 26.7M-9.6% over the window

52W low

$236.73

52W high

$396.23

From 52W high

-4.67%

From 52W low

+59.55%

52W range

88%

Volume

Rel volume

0.84×

30D volume

272.1K

30D $ vol

103.3M

Fundamentals

Sales (ttm)

2.6B2016-06 2B2026-06 2.6B+27.6% over the window

Sales/share

$96.842016-06 $68.562026-06 $96.84+41.2% over the window

EPS (ttm)

$8.262016-06 $3.202026-06 $8.26+158.1% over the window

FCF (ttm)

353.1M2016-06 78.3M2026-06 353.1M+350.7% over the window

FCF/share

$13.212016-06 $2.652026-06 $13.21+398.8% over the window

Book value/share

$268.302016-06 $88.362026-06 $268.30+203.6% over the window

Net margin

8.59%2016-06 4.7%2026-06 8.6%+84.4% over the window

ROE

3.10%2016-06 3.6%2026-06 3.1%-14.2% over the window

ROA

2.17%2016-06 2.4%2026-06 2.2%-11.1% over the window

Debt / equity

0.11×2016-06 0.172026-06 0.11-32.6% over the window

Current ratio

3.142016-06 4.402026-06 3.14-28.6% over the window

Growth (CAGR, ttm) · 10Y

Sales

+1.38%2025-06-30 → 2026-06-302.6B → 2.6B (+1.4% total)-2.21%2023-06-30 → 2026-06-302.8B → 2.6B (-6.5% total)-2.10%2021-06-30 → 2026-06-302.9B → 2.6B (-10.1% total)+2.47%2016-06-30 → 2026-06-302B → 2.6B (+27.6% total)

Net income

-30.34%2025-06-30 → 2026-06-30319.2M → 222.4M (-30.3% total)n/a-44.04%2021-06-30 → 2026-06-304.1B → 222.4M (-94.5% total)+8.94%2016-06-30 → 2026-06-3094.5M → 222.4M (+135.3% total)

FCF

-4.83%2025-06-30 → 2026-06-30371M → 353.1M (-4.8% total)+31.84%2023-06-30 → 2026-06-30154.1M → 353.1M (+129.2% total)-9.65%2021-06-30 → 2026-06-30586.5M → 353.1M (-39.8% total)+16.25%2016-06-30 → 2026-06-3078.3M → 353.1M (+350.7% total)

Shares

-1.20%2025-06-30 → 2026-06-3027.1M → 26.7M (-1.2% total)-2.75%2023-06-30 → 2026-06-3029.1M → 26.7M (-8.0% total)-2.13%2021-06-30 → 2026-06-3029.8M → 26.7M (-10.2% total)-1.01%2016-06-30 → 2026-06-3029.6M → 26.7M (-9.6% total)

Per-share growth (CAGR, ttm) · 10Y

EPS

-29.61%2025-06-30 → 2026-06-30$11.73 → $8.26 (-29.6% total)n/a-42.76%2021-06-30 → 2026-06-30$134.32 → $8.26 (-93.9% total)+9.95%2016-06-30 → 2026-06-30$3.20 → $8.26 (+158.1% total)

Sales/share

+2.61%2025-06-30 → 2026-06-30$94.38 → $96.84 (+2.6% total)+0.56%2023-06-30 → 2026-06-30$95.23 → $96.84 (+1.7% total)+0.02%2021-06-30 → 2026-06-30$96.73 → $96.84 (+0.1% total)+3.51%2016-06-30 → 2026-06-30$68.56 → $96.84 (+41.2% total)

FCF/share

-3.67%2025-06-30 → 2026-06-30$13.71 → $13.21 (-3.7% total)+35.57%2023-06-30 → 2026-06-30$5.30 → $13.21 (+149.2% total)-7.69%2021-06-30 → 2026-06-30$19.70 → $13.21 (-33.0% total)+17.44%2016-06-30 → 2026-06-30$2.65 → $13.21 (+398.8% total)

Book value/share

+1.86%2025-06-30 → 2026-06-30$263.42 → $268.30 (+1.9% total)-2.62%2023-06-30 → 2026-06-30$290.51 → $268.30 (-7.6% total)-7.18%2021-06-30 → 2026-06-30$389.45 → $268.30 (-31.1% total)+11.75%2016-06-30 → 2026-06-30$88.36 → $268.30 (+203.6% total)

Price

+34.74%2025-09-30 → 2026-09-30$280.39 → $377.71 (+34.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+1.76%2023-09-29 → 2026-09-30$358.45 → $377.71 (+5.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-12.73%2021-09-30 → 2026-09-30$745.95 → $377.71 (-49.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+8.84%2016-09-29 → 2026-09-30$161.96 → $377.71 (+133.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

+34.74%2025-09-30 → 2026-09-30$280.39 → $377.71 (+34.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.76%2023-09-29 → 2026-09-30$358.45 → $377.71 (+5.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-12.73%2021-09-30 → 2026-09-30$745.95 → $377.71 (-49.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+8.84%2016-09-29 → 2026-09-30$161.96 → $377.71 (+133.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

45.7×2016-12 57.412026-09 45.41-20.9% over the window

P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.

190.2×2016-12 41.832026-09 190.19+354.6% over the window

Fwd P/E

37.7×

P/S (ttm)Market cap ÷ TTM revenue.

3.9×2016-12 2.622026-09 3.90+49.1% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

1.4×2016-12 2.002026-09 1.41-29.7% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

28.6×2016-12 164.112026-09 28.60-82.6% over the window

EV/EBITDA (fy)

44.5×

EV/Sales (ttm)

3.7×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

3.50%2016-09 0.6%2026-06 4.5%+638.1% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 26.7M ÷ 27.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

1.20%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (1.20%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($6.5B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

1.20%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($133.6M) ÷ today's market cap ($10.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

1.32%2016-09 -0.2%2026-06 1.7%-846.0% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $133.6M + TTM dividends $0) ÷ today's market cap ($10.1B). Same caveat as the cash buyback yield.

1.32%2016-09 -0.2%2026-06 1.7%-846.0% over the window

Vs own 10Y history

P/E

74th

P/OI

94th

P/S

51st

P/B

37th

P/FCF

17th